Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,788
Closed -$1.85M 442
2023
Q3
$1.85M Buy
19,788
+512
+3% +$57.7K 0.21% 98
2023
Q2
$2.48M Buy
+19,276
New +$2.33M 0.28% 71

Other funds holding DXCM

Good Life Advisors's DXCM Position: Q4 2023 in Review

Good Life Advisors sold out of DexCom (DXCM) in Q4 2023, closing a stake of 19,788 shares — an estimated $1.85M sold.

Good Life Advisors first reported a position in DXCM in Q2 2023 and held it in 2 quarters. The position peaked at $2.48M in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Good Life Advisors reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Good Life Advisors sold 19,788 DexCom shares in Q4 2023, an estimated $1.85M.
  • Good Life Advisors first reported a position in DexCom in Q2 2023 and held it in 2 quarters.
  • Good Life Advisors's DexCom position peaked at $2.48M in Q2 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Good Life Advisors's 13F filing for Q4 2023, filed 18 Jan 2024.